Aviva’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.8M Buy
192,660
+11,970
+7% +$5.33M 0.18% 119
2025
Q1
$87.6M Buy
180,690
+25,200
+16% +$12.2M 0.21% 105
2024
Q4
$62.6M Buy
155,490
+30,650
+25% +$12.3M 0.16% 127
2024
Q3
$58.1M Buy
124,840
+2,923
+2% +$1.36M 0.15% 157
2024
Q2
$57.1M Buy
121,917
+23,916
+24% +$11.2M 0.16% 130
2024
Q1
$41M Sell
98,001
-28,982
-23% -$12.1M 0.13% 180
2023
Q4
$51.7M Buy
126,983
+17,357
+16% +$7.06M 0.19% 107
2023
Q3
$38.1M Buy
109,626
+8,816
+9% +$3.07M 0.16% 119
2023
Q2
$35.5M Sell
100,810
-55,572
-36% -$19.6M 0.14% 153
2023
Q1
$49.3M Buy
156,382
+4,121
+3% +$1.3M 0.22% 96
2022
Q4
$44M Sell
152,261
-18,744
-11% -$5.41M 0.22% 103
2022
Q3
$49.5M Sell
171,005
-23,816
-12% -$6.9M 0.29% 61
2022
Q2
$54.9M Buy
194,821
+47,073
+32% +$13.3M 0.29% 62
2022
Q1
$38.6M Buy
147,748
+54,224
+58% +$14.2M 0.19% 102
2021
Q4
$20.5M Sell
93,524
-8,617
-8% -$1.89M 0.09% 221
2021
Q3
$18.5M Buy
102,141
+6,025
+6% +$1.09M 0.08% 243
2021
Q2
$19.4M Buy
96,116
+9,156
+11% +$1.85M 0.09% 238
2021
Q1
$18.7M Sell
86,960
-416
-0.5% -$89.4K 0.09% 209
2020
Q4
$20.7M Buy
87,376
+3,535
+4% +$835K 0.11% 192
2020
Q3
$22.8M Sell
83,841
-2,712
-3% -$738K 0.13% 135
2020
Q2
$25.1M Sell
86,553
-4,520
-5% -$1.31M 0.16% 121
2020
Q1
$21.7M Buy
91,073
+984
+1% +$234K 0.16% 117
2019
Q4
$19.7M Sell
90,089
-504
-0.6% -$110K 0.12% 155
2019
Q3
$15.3M Sell
90,593
-3,548
-4% -$601K 0.1% 181
2019
Q2
$17.3M Sell
94,141
-2,340
-2% -$429K 0.12% 168
2019
Q1
$17.7M Buy
96,481
+175
+0.2% +$32.2K 0.12% 173
2018
Q4
$16M Sell
96,306
-26,489
-22% -$4.39M 0.12% 182
2018
Q3
$23.7M Sell
122,795
-4,353
-3% -$839K 0.13% 168
2018
Q2
$21.6M Sell
127,148
-835
-0.7% -$142K 0.13% 173
2018
Q1
$20.9M Sell
127,983
-12,550
-9% -$2.05M 0.13% 174
2017
Q4
$21.1M Sell
140,533
-17,545
-11% -$2.63M 0.12% 193
2017
Q3
$24M Buy
158,078
+3,420
+2% +$520K 0.13% 183
2017
Q2
$19.9M Buy
154,658
+1,980
+1% +$255K 0.11% 212
2017
Q1
$16.7M Sell
152,678
-8,487
-5% -$928K 0.1% 233
2016
Q4
$11.9M Buy
161,165
+10,610
+7% +$782K 0.07% 294
2016
Q3
$13.1M Buy
150,555
+3,286
+2% +$287K 0.08% 279
2016
Q2
$12.7M Buy
147,269
+11,649
+9% +$1M 0.09% 264
2016
Q1
$10.8M Buy
135,620
+1,456
+1% +$116K 0.08% 274
2015
Q4
$16.9M Sell
134,164
-797
-0.6% -$100K 0.13% 171
2015
Q3
$14.1M Sell
134,961
-1,808
-1% -$188K 0.12% 205
2015
Q2
$16.9M Buy
136,769
+8,100
+6% +$1M 0.12% 196
2015
Q1
$15.2M Buy
128,669
+32,001
+33% +$3.78M 0.1% 224
2014
Q4
$11.5M Sell
96,668
-210
-0.2% -$24.9K 0.09% 256
2014
Q3
$10.9M Sell
96,878
-80
-0.1% -$8.98K 0.09% 256
2014
Q2
$9.18M Buy
96,958
+200
+0.2% +$18.9K 0.07% 315
2014
Q1
$6.84M Buy
96,758
+4,810
+5% +$340K 0.06% 369
2013
Q4
$6.83M Buy
91,948
+8,344
+10% +$620K 0.06% 360
2013
Q3
$6.34M Sell
83,604
-254,788
-75% -$19.3M 0.06% 353
2013
Q2
$27M Buy
+338,392
New +$27M 0.27% 92